Hancock Holding Co. Has $1.37 Million Position in HCA Holdings, Inc. (HCA)
Hancock Holding Co. boosted its holdings in HCA Holdings, Inc. (NYSE:HCA) by 123.9% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 15,720 shares of the company’s stock after acquiring an additional 8,700 shares during the quarter. Hancock Holding Co.’s holdings in HCA Holdings were worth $1,371,000 at the end of the most recent quarter.
A number of other hedge funds have also added to or reduced their stakes in HCA. Northwestern Mutual Wealth Management Co. raised its stake in HCA Holdings by 14.0% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 1,163 shares of the company’s stock valued at $101,000 after buying an additional 143 shares during the last quarter. Bronfman E.L. Rothschild L.P. raised its stake in HCA Holdings by 35.1% during the 2nd quarter. Bronfman E.L. Rothschild L.P. now owns 1,232 shares of the company’s stock valued at $107,000 after buying an additional 320 shares during the last quarter. Lee Financial Co purchased a new stake in HCA Holdings during the 2nd quarter valued at $125,000. Acrospire Investment Management LLC raised its stake in HCA Holdings by 14.3% during the 2nd quarter. Acrospire Investment Management LLC now owns 1,600 shares of the company’s stock valued at $140,000 after buying an additional 200 shares during the last quarter. Finally, D.A. Davidson & CO. raised its stake in HCA Holdings by 37.7% during the 2nd quarter. D.A. Davidson & CO. now owns 1,970 shares of the company’s stock valued at $171,000 after buying an additional 539 shares during the last quarter. 73.75% of the stock is currently owned by institutional investors and hedge funds.
HCA has been the subject of a number of research reports. Robert W. Baird decreased their target price on shares of HCA Holdings from $95.00 to $93.00 and set an “outperform” rating for the company in a research note on Tuesday, August 22nd. ValuEngine lowered shares of HCA Holdings from a “buy” rating to a “hold” rating in a research note on Thursday, September 7th. Argus initiated coverage on shares of HCA Holdings in a research note on Wednesday, June 28th. They set a “buy” rating and a $100.00 target price for the company. Cantor Fitzgerald reiterated a “buy” rating and set a $95.00 target price on shares of HCA Holdings in a research note on Wednesday, September 6th. Finally, Bank of America Corporation lowered shares of HCA Holdings from a “buy” rating to a “neutral” rating and decreased their target price for the company from $102.00 to $92.00 in a research note on Wednesday, July 26th. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and twelve have given a buy rating to the company. The company presently has an average rating of “Buy” and a consensus price target of $92.88.
In other HCA Holdings news, insider Michael S. Cuffe sold 2,150 shares of HCA Holdings stock in a transaction on Tuesday, August 15th. The shares were sold at an average price of $79.88, for a total value of $171,742.00. Following the completion of the transaction, the insider now owns 12,363 shares of the company’s stock, valued at $987,556.44. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders sold 6,450 shares of company stock valued at $529,309 in the last ninety days. 2.90% of the stock is owned by corporate insiders.
HCA Holdings, Inc. (NYSE:HCA) opened at 78.17 on Thursday. The company has a market cap of $28.24 billion, a P/E ratio of 10.48 and a beta of 0.67. The company has a 50-day moving average of $78.44 and a 200 day moving average of $83.29. HCA Holdings, Inc. has a one year low of $67.00 and a one year high of $91.03.
HCA Holdings (NYSE:HCA) last issued its earnings results on Tuesday, July 25th. The company reported $1.75 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $1.80 by ($0.05). HCA Holdings had a negative return on equity of 48.08% and a net margin of 6.64%. The business had revenue of $10.73 billion for the quarter, compared to analysts’ expectations of $10.76 billion. During the same period last year, the business earned $1.66 EPS. The company’s revenue for the quarter was up 4.0% on a year-over-year basis. Analysts anticipate that HCA Holdings, Inc. will post $7.18 earnings per share for the current year.
TRADEMARK VIOLATION WARNING: This piece was posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this piece on another site, it was illegally copied and reposted in violation of U.S. & international copyright and trademark laws. The correct version of this piece can be read at https://www.thecerbatgem.com/2017/09/28/hancock-holding-co-has-1-37-million-position-in-hca-holdings-inc-hca.html.
HCA Holdings Company Profile
HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Holdings, Inc. (NYSE:HCA).
Receive News & Stock Ratings for HCA Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Holdings Inc. and related stocks with our FREE daily email newsletter.